The lateral hypothalamus (LH) is a key regulator of multiple vital behaviors. The firing of brain-wide-projecting LH neurons releases neuropeptides promoting wakefulness (orexin/hypocretin; OH), or sleep (melanin-concentrating hormone; MCH). OH neurons, which coexpress glutamate and dynorphin, have been proposed to excite their neighbors, including MCH neurons, suggesting that LH may sometimes coengage its antagonistic outputs. However, it remains unclear if, when, and how OH actions promote temporal separation of the sleep and wake signals, a process that fails in narcolepsy caused by OH loss. To explore this directly, we paired optogenetic stimulation of OH cells (at rates that promoted awakening in vivo) with electrical monitoring of MCH cells in mouse brain slices. Membrane potential recordings showed that OH cell firing inhibited action potential firing in most MCH neurons, an effect that required GABA A but not dynorphin receptors. Membrane current analysis showed that OH cell firing increased the frequency of fast GABAergic currents in MCH cells, an effect blocked by antagonists of OH but not dynorphin or glutamate receptors, and mimicked by bath-applied OH peptide. In turn, neural network imaging with a calcium indicator genetically targeted to MCH neurons showed that excitation by bath-applied OH peptides occurs in a minority of MCH cells. Collectively, our data provide functional microcircuit evidence that intra-LH feedforward loops may facilitate appropriate switching between sleep and wake signals, potentially preventing sleep disorders.
Introduction
The lateral hypothalamus (LH), historically seen as a vital source of wakefulness signals, is now known to coordinate arousal, sleep, and energy balance de Lecea, 2012; Jego and Adamantidis, 2013) . It contains a heterogeneous population of neurons, including those expressing the neuropeptides orexin/hypocretin (OH) or melanin-concentrating hormone (MCH), both of which send wide projections throughout the brain (Bittencourt et al., 1992; Trivedi et al., 1998) . In several respects, OH and MCH neurons exert antagonistic actions on brain state and energy balance. Deletion of OH causes inappropriate sleepiness (narcolepsy) and weight gain (Chemelli et al., 1999; Hara et al., 2001) , whereas deletion of MCH or the MCH receptor 1 results in increased hyperactivity and leanness (Shimada et al., 1998; Marsh et al., 2002; Takase et al., 2014) . OH cell activation produces awakening , whereas MCH cell activation promotes REM sleep (Jego et al., 2013; Tsunematsu et al., 2014) . Chronic activation of MCH cells randomly and independently of sleep state can also increase NREM sleep (Jego and Adamantidis, 2013; Konadhode et al., 2013) .
In vivo recordings suggest that MCH neurons fire during REM sleep, whereas OH neurons fire during wakefulness (Hassani et al., 2009 ). However, bath application of OH peptides can excite MCH neurons in vitro (van den Pol et al., 2004; Li and van den Pol, 2006) . Hypothetically, these apparently contradictory observations could be reconciled if OH cell activity had a dual effect on the MCH network. For example, excitation of some MCH cells by OH may result in coactivation of antagonist signals, which is considered useful for fine control in some systems (Smith, 1981; Baratta et al., 1988; Cui et al., 2013 : Tecuapetla et al., 2014 . Concurrently, OH-dependent wakefulness would be protected from sleep intrusions if most MCH neurons were inhibited by OH cell firing, through as yet unidentified circuits. These hypotheses can be directly investigated by recording from MCH cells during OH cell firing, and by examining OH peptide effects at the level of MCH cell network. Recent technological advances allow the latter to be assessed by network-level calcium imaging (Chen et al., 2013) , and the former by optogenetics-assisted circuit analysis (Petreanu et al., 2007) . Here we apply both of these tools to explore how OH cell activity influences MCH neurons.
Materials and Methods
Gene transfer. Animal procedures followed United Kingdom Home Office regulations. AAV constructs carrying channelrhodopsin-2 (ChR2) and lentiviruses expressing mCherry under the control of MCH promoter were bilaterally stereotactically coinjected into the LH of orexin-cre mice of either sex (Matsuki et al., 2009; Sasaki et al., 2011) . This targets ChR2 expression to OH neurons (Schöne et al., 2012) . To target expression of mCherry to MCH neurons, we used a lentiviral vector carrying the 0.9 kb preproMCH gene promoter. The specificity of lentivirus-mediated expression was tested by stereotactic delivery of MCH::mCherry lentiviral vector (Ͼ10 9 pfu/ml) into the LH of MCH::eGFP transgenic mice (Stanley et al., 2010) , and confirmed by staining with MCH antibody (see Fig. 2 ). The MCH::mCherry lentivirus used in this study was generated by Penn Vector Core, University of Pennsylvania (VSVG.HIV.MCH.mCherry(p2428), titer 3.16 ϫ 10 11 gc/ ml. AAV vectors delivering ChR2 were also produced by the Penn Vector Core; we used AAV2-EF1a-DIO-ChR2(E123T/T159C)-eYFP or AAV1.EF1a.DIO.hChR2(H134R)-eYFP.WPRE.hGH. The titers of ChR2-AAVs were Ͼ1.4 ϫ 10 13 gc/ml. Three 100 nl injections of the mixed viruses were made at: Ϫ1.3 to Ϫ1.4 mm from bregma; Ϯ0.9 mm from midline; and Ϫ5.30, Ϫ5.15, and Ϫ5.00 mm from skull surface. For calcium imaging, AAV carrying cre-dependent GCaMP6s (rAAV9.CAG.Flex.GCaMP6s.WPRE.SV40; Penn Vector Core, lot CS0419, titer 2.74 ϫ 10 13 gc/ml) was bilaterally stereotaxically injected into LH of MCH-cre mice (Kong et al., 2010) . Three 50 nl injections of the GCaMP6s virus were at: Ϫ1.35 mm from bregma; Ϯ0.9 mm from midline; and Ϫ5.30, Ϫ5.20, and Ϫ5.10 mm from brain surface. To confirm the selectivity of the Tg(Pmch-Cre) transgenic mice, animals were crossed with cre-dependent TdTomato reporter (Rosa-CAG-LSLtdTomato-WPRE, line Ai9, Jackson Laboratories) and immunostained for MCH. 85.87 Ϯ 1.41% of MCH-immunopositive cells were found to express TdTomato, whereas 99.81 Ϯ 0.09% of TdTomato cells expressed MCH (2432 cells, n ϭ 3 mice). GCaMP6s fluorescence was not seen after the AAV coding for GCaMP6s was injected into the LH of wild-type mice (n ϭ 3 mice), confirming that it was selective to cre-containing neurons.
Calcium imaging, electrophysiology, and photostimulation. Four to six weeks after stereotactic injections, acute brain slices were prepared as in our previous work (Schöne et al., 2012) . Mice were maintained on a standard 12 h light/dark cycle, and slice recordings performed in both the light (11:00 A.M. to 6:00 P.M.) and dark (6:00 P.M. to 9:00 P.M.) parts of the cycle, with similar results. For calcium imaging, brain slices were placed in a recording chamber of an upright microscope (BX61WI, Olympus) controlled by the Olympus Fluoview software (FV10-ASW ver 4.0), and perfused at 35°C with ACSF. Confocal imaging was performed at 4 Hz frame-rate through an Olympus 20ϫ 0.50 NA objective, with a 488 nm Argon laser excitation, and 500 -545 nm spectral detector emission collection. Movies were motion-corrected (StackReg plugin, ImageJ). A region of-interest (ROI) around each GCaMP6s-positive cell body was selected using the ROI manager in ImageJ. The ROI locations were used to extract the mean fluorescence value for each object on each frame F(t). To correct for background activity and normalize for the fluorescence value of each cell, we first separated experimental trials into two parts: a baseline period corresponding to all the frames recorded before one frame after the presentation of orexin, and a stimulus period, beginning 4 s after the onset of orexin application and lasting 10 min. Next, for each ROI we calculated %dF/F for each frame (t), where dF/F ϭ (F(t) Ϫ F) *100/F, and F was the mean fluorescence value for that ROI for all frames in the baseline period for that trial. For whole-cell patch-clamp recordings, performed and analyzed as in our previous work (Schöne et al., 2012) , MCH cells were visualized in acute living brain slices using a mCherry filter set (Chroma). To stimulate ChR2, we used a Thorlabs blue LED, delivering ϳ10 mW/mm 2 light to ChR2-containing axons around the recorded cell through a 40ϫ 0.8 NA objective. Whole-cell recordings were performed at 37°C using an EPC-10 amplifier and Patch-Master software (HEKA Elektronik). Averaged data are presented as the mean Ϯ SEM. Statistical significance was evaluated using ANOVA with Bonferonni post-test, unless stated otherwise.
Chemicals and solutions. Slice-cutting and recording ACSF was gassed with 95% O 2 and 5% CO 2 , and contained the following (mM): 125 NaCl, 25 NaHCO 3 , 3 KCl, 1.25 NaH 2 PO 4 , 1/2 CaCl 2 (cutting/recording), 6/1 MgCl 2 (cutting/recording), 3 sodium pyruvate, and 25/5 glucose (cutting/recording). Pipettes were filled with (in mM): 135 potassium gluconate, 7 NaCl, 10 HEPES, 2 Na 2 -ATP, 0.3 Na-GTP, and 2 MgCl 2 ; pH was adjusted to 7.3 with KOH. Drug concentrations were (in m): 20 CNQX and 100 AP5, 10 gabazine, 1 TTX, 5 nor-binaltorphimine dihydrochloride (nor-BNI), 10 SB-334867 (SB), and 10 TCS-OX2-29 (TCS). All chemicals were from Signal, Tocris Bioscience, or Bachem.
Immunocytochemistry. Primary antibodies were as follows: goat antiorx-B (1:1000; Santa Cruz Biotechnology), rabbit anti-GABA (1:500; Immunostar), and rabbit anti-MCH (1:1000, Phoenix Pharmaceuticals) Secondary antibodies were AlexaFluor 594 donkey anti-rabbit and AlexaFluor 488 donkey anti-goat (both 1:1000; Thermo Fisher). Orexin, MCH, and biocytin immunostaining was performed as in our previous work . For GABA immunostaining, tissue was heated to 80°C for 30 min in sodium citrate (pH 8; Sigma-Aldrich), washed in 0.1 M PBS, treated three times for 5 min in sodium borohydride solution (1 mg/ml in PBS), again washed in 0.1 M PBS, and blocked/ permeabilized in PBS with 0.3% Triton X-100 (Sigma-Aldrich) and 5% donkey serum (Sigma-Aldrich). Sections were then incubated overnight in blocking solution with rabbit anti-GABA and goat anti-orx-B. On Day 2, tissue was washed in 0.1 M PBS, incubated in secondary antibodies for 2 h, washed in PBS, and mounted on microscope slides and coverslipped. Digital images were captured with a Zeiss Axioskop 2 microscope and QImaging QICAM Fast digital camera. Images were merged using ImageJ (National Institutes of Health). Expression was analyzed separately and subsequently merged and counted manually.
Results

Artificially applied orexin/hypocretin excites a minor part of the MCH network
To explore OH peptide effects on MCH network, we first targeted genetically encoded calcium indicators selectively to MCH neurons in MCH-cre transgenic mice (see Materials and Methods; Fig. 1A ). This allows monitoring of neuronal excitation by using cytosolic calcium concentration as a proxy (Chen et al., 2013) . In this assay, ϳ30% of MCH neurons were activated by 1 M bathapplied orexin-A; the rest were either unaffected or inhibited (Fig. 1A) . Second, we performed whole-cell current-clamp recordings, where bath application of 1 M orexin-A also had mixed effects on MCH cell membrane potential: some MCH neurons slightly depolarized, but others were hyperpolarized or did not respond (2/6 and 4/6 cells, respectively; Fig. 1B) . These results are consistent with previous work showing that some MCH neurons can be activated by 1 M artificially applied orexin (van den Pol et al., 2004; Li and van den Pol, 2006) , but our data suggest that this activation occurs in a minority of MCH cells.
Firing of OH neurons exerts inhibitory effects on MCH cell membrane potential
Artificial application of neurotransmitters involves arbitrarily chosen concentrations that may not correspond to those in native neural networks, potentially creating unnatural responses (e.g., due to receptor desensitization). To examine intrinsic signals generated by OH cell firing in MCH neurons, we performed optogenetic analysis of functional connectivity in LH brain slices. To selectively stimulate OH cells while recording from identified MCH cells, we expressed light-activated excitatory ion channel ChR2 in OH neurons and simultaneously transduced MCH neurons using lentiviral vector expressing the mCherry fluorescent protein driven by an MCH gene promoter ( Fig. 2A ; see Materials and Methods). Following stereotaxic injections of the mCherry-MCH lentiviruses into the LH, mCherry-labeled neurons were found only in the previously reported locations of MCH neurons (the Zona Incerta, Lateral and Dorsomedial Hypothalamus; Fig.  2 A, B1 ). MCH-like immunoreactivity was found in 98.7% of mCherry-labeled cells ( Fig. 2A ; statistics for data shown in the figures are reported in figure legends). Whole-cell recordings from the mCherry cells (Fig. 2B5 ) revealed typical membrane potential "signatures" of MCH cells , confirming that MCH cell function was unperturbed by the viral infection. The firing of most MCH-mCherry cells was rapidly reduced when OH-ChR2 cells were optically paced at a frequency that we previously found to cause awakening in vivo (20 Hz; Adamantidis et al., 2007;  Fig. 2C ; n ϭ 25/32 cells; note that this represents Ϸ80% of MCH cells with only Ϸ40% of OH cells transfected with ChR2 in our preparation; Schöne et al., 2012). Lower optical stimulation frequencies were less effective (Fig.  2C2) , mirroring stimulation requirement for OH peptide release in slices (Schöne et al., 2014) . Dynorphin is coexpressed in OH neurons (Muschamp et al., 2014) , and extrinsic application of dynorphin can inhibit MCH neurons via -opiod receptors (Li and van den Pol, 2006) . However, the -opiod receptor antagonist Nor-BNI did not affect the inhibition of MCH activity by OH cell firing (Fig. 2C2) . In contrast, the OH ¡ MCH inhibition was largely abolished by 10 M gabazine, a GABA A receptor blocker, suggesting that it is mediated by local GABA release (Fig. 2C2) .
OH cell firing controls GABA input to MCH cells via OH receptors
To further investigate synaptic currents underlying the GABAergic suppression of MCH cell activity during OH cell firing, we performed voltage-clamp recordings (at Ϫ80 mV) in glutamate receptor blockers (CNQXϩAP5). Optical stimulation significantly increased the frequency of gabazine-sensitive IPSCs (Fig.  3A) . IPSC frequency increased progressively during optical stimulation (Fig. 3A2) , similar to actions of OH peptides expected to be released by this stimulation (Schöne et al., 2014) . Application of OH receptor antagonists substantially reduced the ability of the optical stimulation to increase GABAergic tone (Fig. 3A) . In contrast, -opiod receptor antagonist did not affect the IPSC stimulation (Fig. 3A2,3 ). If our optical stimulation increases GABA input to MCH cells by releasing endogenous OH peptides, then the increase in GABAergic tone should be mimicked by artificially applied OH peptides. Indeed, bath-applied OH peptide significantly increased the frequency of miniature GABA Amediated IPSCs (Fig. 3B) .
Interestingly, in some cases we observed GABA A -mediated IPSCs in MCH neurons that appeared time-locked (2-10 ms latency) to the optical flashes stimulating OH neurons (Fig.  4A) . The probability of the short-latency (Ͻ10 ms) IPSCs was also increased by bath-applied OH peptide (Fig. 4A3) . It has been suggested that latencies Ͼ1.8 ms may represent indirect, polysynaptic connections (Gil and Amitai, 1996) . Thus, our latencies could mean that OH neurons fire GABA interneurons projecting to MCH cells, presumably by releasing OH peptide since the responses persisted in glutamate receptor blockers (Fig. 4A1) . Alternatively, due to delays between optical flashes and the spikes they evoke in ChR2-expressing cells (Tecuapetla et al., 2010) , it cannot be excluded that some OH cells may release GABA onto MCH cells. Indeed, it has been previously hypothesized based on immunocytochemistry, real-time PCR, and electron-microscopy that a subgroup of OH cells may release GABA Harthoorn et al., 2005; Balcita-Pedicino and Sesack, 2007) . We confirmed that GABA-like immunoreactivity is present in a subpopulation of OH neurons (10 -25% of OH cells, depending on LH area; Fig. 4B , but see Discussion).
At least some MCH cells are GABAergic (Jego et al., 2013) , and some may be excited by OH neurons ( Fig. 1A1 ; van den Pol et al., 2004; Li and van den Pol, 2006) . This suggests a possibility that some of OH-dependent GABA drive to MCH neurons may come from other MCH neurons. To test this, we performed dual whole-cell recordings from identified MCHmCherry cell pairs (Fig. 4C) . We generated action potentials in one MCH cell, while recording synaptic responses in another MCH cell. We did not find evidence of MCH-to-MCH functional connectivity: presynaptic action potentials did not generate detectable postsynaptic responses in 43 MCH-MCH cell pairs tested (Fig. 4C) .
Discussion
A key question in systems neuroscience is how the brain ensures that opposing signals, such those causing sleep and wake transitions, are scheduled to occur at separate times. Inappropriate co-occurrence of such signals can produce pathological brain states and behaviors, for example concurrent wakefulness and sleep-paralysis (Dauvilliers et al., 2007) . Our results provide a network-level explanation for how such pathological mixing of opposing neural drives may be prevented by natural LH microcircuits. Our data suggest that when OH neurons fire at rates that promote awakening , the spike output of most MCH neurons is suppressed, due to increased GABAergic drive into those cells (Fig. 2C) . The GABAergic inhibition of MCH cells depends significantly on OH receptors, whereas glutamate receptors are not essential (Fig. 3A2) . This is consistent with our previous data that OH (but not glutamate) transmission is critical for translating OH cell firing into sustained postsynaptic electrical responses (Schöne et al., 2014) . Our data are also consistent with the possibility that OH may release GABA themselves (Fig. 4) . However, further molecular and ultra-structural data would be necessary to ascertain how OH cells may produce GABA and/or package it into vesicles, because the GABA staining we observed may be cytosolic (and not vesicular), and we found no evidence of OH immunoreactivity in vgat-positive neurons of the LH (D. Burdakov and J. Apergis-Schoute, unpublished observations). It remains to be determined whether OH neurons may acquire GABAergic functional identity through noncanonical transporters, such as recently reported for dopamine neurons (Tritsch et al., 2012 (Tritsch et al., , 2014 . More broadly, our results offer a reconciliation for the apparent contradictions in existing in vitro and in vivo data on relative timing of OH and MCH cell activity (van den Pol et al., 2004; Hassani et al., 2009 ). Although we observed only inhibitory effects during intrinsic OH cell ¡ MCH cell actions (consistent with Hassani et al., 2009) , our data with bath applications of OH peptide suggested that it may also directly excite some MCH neurons (consistent with van den Pol et al., 2004) . It is possible that the high levels of OH peptide required to excite MCH cells are not attained during optogenetic stimulation in slices or during acute experiments. In vivo, during overexcitation of OH cells, it remains possible that OH peptides may reach high-enough levels to excite MCH cells directly, which may provide a feedback mechanism preventing hyperarousal. In terms of natural drives of OH neurons, there is evidence that noradrenaline input to OH cells may switch sign after sleep deprivation due to a switch in receptor type (Grivel et al., 2005; Uschakov et al., 2011) . This suggests the coupling of MCH cell activity to arousal state in general, and to noradrenaline drive in particular, may change as a function of stress or sleep pressure, an interesting possibility that deserves future investigation.
We predict that the OH receptor-dependent intrinsic OH ¡ MCH inhibitory signaling (Fig. 3A2) is mediated by local OHexcited GABA neurons. It would be important to determine the identities of these neurons in future investigations, and our paired recordings (Fig. 4C ) currently suggest that these GABA cells may be separate from MCH neurons themselves. At the level of local circuits in the LH, our data provide functional experimental support for the "flip-flop" model of binary switching between sleep and wake signals . The GABAergic microcircuits mediating OH ¡ MCH cell inhibition may constitute a new therapeutic target, because they are likely to oppose the pathological mixing of sleep and wake states in disorders such as narcopelsy.
